Rxo (RXO) Receivables (2021 - 2026)

Rxo (RXO) has reported Receivables for 6 consecutive years, with $1.2 billion the latest figure, recorded in Q1 2026.

• Receivables for Q1 2026 came in at $1.2 billion, up 5.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 5.74% YoY), and the FY2025 annual result was $1.3 billion, up 0.64% from the prior year.
• Receivables was $1.2 billion for Q1 2026 at Rxo, down from $1.3 billion in the prior quarter.
• Over five years, Receivables peaked at $1.3 billion in Q4 2025 and troughed at $716.0 million in Q1 2024.
• Average Receivables over 5 years is $978.2 million, with a median of $1.0 billion recorded in 2022.
• Year-over-year, Receivables fell 22.62% in 2023 and surged 64.99% in 2024.
• Over 5 years, Receivables stood at $900.0 million in 2022, then fell by 16.22% to $754.0 million in 2023, then soared by 64.99% to $1.2 billion in 2024, then grew by 0.64% to $1.3 billion in 2025, then slipped by 2.88% to $1.2 billion in 2026.
• Per Business Quant data, the three most recent Receivables figures were $1.2 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.1 billion in Q3 2025.